Design Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Design Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Design Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Design Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.2M | 554k | 7.53 |
| 2025-06-30 | $2.8M | 841k | 3.37 |
| 2025-03-31 | $3.7M | 971k | 3.86 |
| 2024-12-31 | $6.0M | 966k | 6.17 |
| 2024-09-30 | $3.1M | 581k | 5.38 |
| 2024-06-30 | $1.0M | 313k | 3.35 |
| 2024-03-31 | $3.5M | 875k | 4.03 |
| 2023-12-31 | $4.9M | 1.8M | 2.65 |
| 2023-09-30 | $6.4M | 2.7M | 2.36 |
| 2023-06-30 | $18M | 2.9M | 6.30 |
| 2023-03-31 | $17M | 2.9M | 5.77 |
| 2022-12-31 | $28M | 2.7M | 10.26 |
| 2022-06-30 | $38M | 2.7M | 14.00 |
| 2022-03-31 | $41M | 2.5M | 16.15 |
| 2021-12-31 | $54M | 2.5M | 21.41 |
| 2021-09-30 | $38M | 2.6M | 14.70 |
| 2021-06-30 | $51M | 2.6M | 19.88 |
| 2021-03-31 | $76M | 2.5M | 29.90 |